NASDAQ: TXMD
Therapeuticsmd Inc Stock Ownership - Who owns Therapeuticsmd?

Insider buying vs selling

Have Therapeuticsmd Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tommy G. ThompsonDirector2025-04-14325$1.00
$325.65Buy
Marlan D. WalkerChief Executive Officer2025-04-14490$1.00
$489.51Buy
Marlan D. WalkerChief Executive Officer2025-04-101,167$0.86
$1.00kBuy
Marlan D. WalkerChief Executive Officer2025-04-091,136$0.88
$994.00Buy
Cooper C. CollinsDirector2024-08-224,094$1.73
$7.10kBuy
Cooper C. CollinsDirector2024-08-211,200$1.70
$2.04kBuy

1 of 1

TXMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXMD insiders and whales buy or sell their stock.

TXMD Shareholders

What type of owners hold Therapeuticsmd Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Brian Bernick265.18%30,693,311$37.75MInsider
Robert G. Finizio172.72%19,991,637$24.59MInsider
John Ck Milligan Iv88.40%10,231,927$12.59MInsider
Nicholas Segal42.06%4,868,382$5.99MInsider
Kimberly Sarubbi35.49%4,108,107$5.05MInsider
Robin Natalie Tjon35.49%4,108,107$5.05MInsider
Sky B. Kelley29.58%3,423,422$4.21MInsider
Rubric Capital Management LP25.46%2,946,908$3.62MInsider
Cooper C. Collins23.26%2,692,095$3.31MInsider
Tommy G. Thompson22.24%2,574,614$3.17MInsider

1 of 3

TXMD vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXMD3.85%96.15%Net BuyingNet Buying
QNTM3.03%0.00%
FLGC2.83%48.46%Net Buying
DRRX8.92%91.08%
SXTC0.27%0.00%

Therapeuticsmd Stock Ownership FAQ

Who owns Therapeuticsmd?

Therapeuticsmd (NASDAQ: TXMD) is owned by 30.49% institutional shareholders, 761.03% Therapeuticsmd insiders, and 0.00% retail investors. Brian Bernick is the largest individual Therapeuticsmd shareholder, owning 30.69M shares representing 265.18% of the company. Brian Bernick's Therapeuticsmd shares are currently valued at $38.06M.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.